Botswana

A descriptive summary of the WHO availability assessments of medical abortion medicines in eight African countries

Amy Grossman
Ndola Prata
Sarah Jones
Laurence Läser
Bela Ganatra
Antonella Lavelanet
Natalie Williams
Chilanga Asmani
Hayfa Elamin
Leopold Ouedraogo
Lucy Sejo Maribe
Dina Vladimirovna Gbenou
Yelmali Clotaire Hien
Moussa Dadjoari
Fousséni Dao
Mariette Claudia Adame Gbanzi
Robert Mulunda Kanke
Franck Biayi Kanumpepa
Dudu Dlamini
Grace Motsoanku Mefane
Sirak Hailu Bantiewalu
Mary Nana Ama Brantuo
Olive Sentumbwe-Mugisa
Richard Mugahi
Olumuyiwa Adesanya Ojo
Adeniyi Kolade Aderoba
Ulrika Rehnström Loi
2024

Background: The use of medical abortion using either a combination of mifepristone and misoprostol, or misoprostol alone has contributed to increased safety and decreased mortality and morbidity. The availability of quality medical abortion medicines is an essential component in the provision of quality abortion care. Understanding the factors that influence the availability of medical abortion medicines is important to help in-country policymakers, program planners, and providers improve availability and use of medical abortion.

Methods: Using a...